Literature DB >> 3082748

Evidence for the in vivo production and release into the serum of a T-cell lymphokine, persisting-cell stimulating factor (PSF), during graft-versus-host reactions.

R M Crapper, J W Schrader.   

Abstract

The T-cell lymphokine, persisting-cell stimulating factor (PSF or interleukin-3), was detected in the serum of mice undergoing graft-versus-host reactions (GVHR). Gel filtration under non-dissociating conditions indicated that the PSF in the serum had an apparent molecular weight of 34,000, a figure identical with that of PSF generated from activated T cells in vitro, indicating that PSF was not bound by serum proteins. The GVHR was accompanied by increases in the numbers in the bone marrow and spleen of precursors of PSF-dependent mast cells, and increases in the numbers of mast cells, megakaryocytes and immature and mature neutrophils in the spleen. These effects of GVHR on haemopoietic cells paralleled those seen when haemopoietic tissues were stimulated with pure PSF in vitro and closely resembled those induced in previous studies by the presence of a tumour that secreted PSF alone. These studies are the first to show that PSF can enter the circulation during immune reactions in vivo and suggest that much of the stimulation of haemopoietic cells seen in GVHR, can be accounted for by the release of PSF from activated T cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3082748      PMCID: PMC1453851     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  24 in total

1.  Analysis of true anti-hapten cytotoxic clones in limit dilution microcultures after correction for "anti-self" activity: precursor frequencies, Ly-2 and Thy-1 phenotype, specificity, and statistical methods.

Authors:  M F Good; A W Boyd; G J Nossal
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

Review 2.  Autoimmunization and lymphomagenesis in parent to F1 combinations differing at the major histocompatibility complex: model for spontaneous disease caused by altered self-antigens?

Authors:  E Gleichmann; H Gleichmann; W Wilke
Journal:  Transplant Rev       Date:  1976

3.  A T cell-derived factor stimulating multipotential hemopoietic stem cells: molecular weight and distinction from T cell growth factor and T cell-derived granulocyte-macrophage colony-stimulating factor.

Authors:  J W Schrader; I Clark-Lewis
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

4.  In in vitro production and cloning of the P cell, a bone marrow-derived null cell that expresses H-2 and Ia-antigens, has mast cell-like granules, and is regulated by a factor released by activated T cells.

Authors:  J W Schrader
Journal:  J Immunol       Date:  1981-02       Impact factor: 5.422

5.  P cell-stimulating factor: biochemical characterization of a new T cell-derived factor.

Authors:  I Clark-Lewis; J W Schrader
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

6.  Biochemical characterization of regulatory factors derived from T cell hybridomas and spleen cells. I. Separation of T cell growth factor and T cell replacing factor from granulocyte-macrophage colony-stimulating factor.

Authors:  I Clark-Lewis; J W Schrader
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

7.  Procedures for the purification of interleukin 3 to homogeneity.

Authors:  J N Ihle; J Keller; L Henderson; F Klein; E Palaszynski
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

8.  Characterization of hemopoietic growth factors from T cells and the myelomonocytic leukemia WEHI-3B.

Authors:  I Clark-Lewis; W R Thomas; J W Schrader
Journal:  Exp Hematol       Date:  1985-05       Impact factor: 3.084

9.  Long-term in vitro culture of murine mast cells. II. Purification of a mast cell growth factor and its dissociation from TCGF.

Authors:  Y P Yung; R Eger; G Tertian; M A Moore
Journal:  J Immunol       Date:  1981-08       Impact factor: 5.422

10.  Histamine production during the anti-allograft response. Demonstration of a new lymphokine enhancing histamine synthesis.

Authors:  M Dy; B Lebel; P Kamoun; J Hamburger
Journal:  J Exp Med       Date:  1981-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.